Premium
Phospho‐ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation
Author(s) -
Ratovitski Edward A.
Publication year - 2013
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2013.09.023
Subject(s) - downregulation and upregulation , microrna , promoter , transcription factor , microbiology and biotechnology , transcription (linguistics) , chemistry , biology , cancer research , gene expression , gene , genetics , linguistics , philosophy
Cisplatin‐induced and ATM‐phosphorylated (p)‐ΔNp63α regulates the expression of epidermal differentiation and skin barrier regulators ( AQP3, CASP14, ALOX12B, and CLDN1) in squamous cell carcinoma (SCC) cells by dual transcriptional and post‐transcriptional mechanisms. We found that p‐ΔNp63α bound to target gene promoters, and regulated the activity of the tested promoters in vitro. P‐ΔNp63α was shown to upregulate miR‐185‐5p and downregulate let7‐5p, which subsequently modulated AQP3, CASP14, ALOX12B and CLDN1 through their respective 3′‐untranslated regions. The introduction of miR‐185‐5p into resistant SCC‐11M cells, which are unable to phosphorylate ΔNp63α, render these cells more sensitive to cisplatin treatment. Further studies of the AQP3, CASP14, ALOX12B, and CLDN1 contributions to chemoresistance may assist in developing novel microRNA‐based therapies for human SCC.